Curatis Holding AG's AGM Approves Board's Proposals

Curatis Holding AG, a pharmaceutical company listed on the SIX Swiss Exchange, held its Annual General Meeting on May 23, 2025, in Liestal, Switzerland. The shareholders overwhelmingly supported the Board of Directors' proposals. This included approving the annual report and financial statements for 2024, re-electing the auditor Forvis Mazars, and endorsing board and management compensation.

In a decisive move, 86.5% of voting shareholders re-elected the entire board for another one-year term. The board comprises Marian Borovsky (Chairman, independent), Günter Graubach, Roland Rutschmann, and Silvio Inderbitzin (independent). The compensation committee, retaining Marian Borovsky, Roland Rutschmann, and Günter Graubach, was also re-elected for a year.